These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 28754688)

  • 41. TRIM65 negatively regulates p53 through ubiquitination.
    Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z
    Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2).
    Li X; Huang L; Gao W
    Med Sci Monit; 2019 Jan; 25():771-777. PubMed ID: 30685767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation.
    Cai X; Gao J; Yan Z; Zhang H; Guo D; Zhang S
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):303. PubMed ID: 38861187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin.
    Fatima S; Shi X; Lin Z; Chen GQ; Pan XH; Wu JC; Ho JW; Lee NP; Gao H; Zhang G; Lu A; Bian ZX
    Mol Oncol; 2016 Feb; 10(2):195-212. PubMed ID: 26474915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling.
    Cai Z; Qian ZY; Jiang H; Ma N; Li Z; Liu LY; Ren XX; Shang YR; Wang JJ; Li JJ; Liu DP; Zhang XP; Feng D; Ni QZ; Feng YY; Li N; Zhou XY; Wang X; Bao Y; Zhang XL; Deng YZ; Xie D
    Cancer Res; 2018 May; 78(10):2536-2549. PubMed ID: 29483096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway.
    Liu Y; Zhuang H; Cao F; Li J; Guo Y; Zhang J; Zhao Q; Liu Y
    Cell Death Dis; 2021 Mar; 12(3):278. PubMed ID: 33723262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
    Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
    Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CCAAT/enhancer-binding protein-β functions as a negative regulator of Wnt/β-catenin signaling through activation of AXIN1 gene expression.
    Park S; Lee MS; Gwak J; Choi TI; Lee Y; Ju BG; Kim CH; Oh S
    Cell Death Dis; 2018 Oct; 9(10):1023. PubMed ID: 30283086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
    Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX
    Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo.
    Jin X; Liu Y; Liu J; Lu W; Liang Z; Zhang D; Liu G; Zhu H; Xu N; Liang S
    PLoS One; 2015; 10(8):e0133770. PubMed ID: 26252773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma.
    Zhang CZ; Chen SL; Wang CH; He YF; Yang X; Xie D; Yun JP
    Cancer Res; 2018 Jan; 78(1):51-63. PubMed ID: 29066512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
    Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
    Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells.
    Zhang Z; Xu C; Zhang X; Huang L; Zheng C; Chen H; Wang Y; Ju H; Yao Q
    Oncol Res; 2017 May; 25(5):691-699. PubMed ID: 28244856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
    Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unraveling the impact of AXIN1 mutations on HCC development: Insights from CRISPR/Cas9 repaired AXIN1-mutant liver cancer cell lines.
    Zhang R; Li S; Schippers K; Eimers B; Niu J; Hornung BVH; van den Hout MCGN; van Ijcken WFJ; Peppelenbosch MP; Smits R
    PLoS One; 2024; 19(6):e0304607. PubMed ID: 38848383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
    Tang Q; Zheng X; Zhang J
    Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GCNT3 regulated MUC13 to promote the development of hepatocellular carcinoma through the GSK3β/β-catenin pathway.
    Kang Q; Tingting W; Bingzi D; Hao Z; Yuwei X; Chuandong S; Chengzhan Z
    Dig Liver Dis; 2024 Sep; 56(9):1572-1581. PubMed ID: 38369410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.
    Zhuang L; Wang X; Wang Z; Ma X; Han B; Zou H; Wu Z; Dong S; Qu Z; Zang Y; Wu L
    Cell Death Dis; 2017 May; 8(5):e2804. PubMed ID: 28518144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.